---
import BaseLayout from '../layouts/BaseLayout.astro';
import HeroSection from '../components/HeroSection.astro';
import CTAButton from '../components/CTAButton.astro';
import FAQAccordion from '../components/FAQAccordion.astro';
---

<BaseLayout
  title="Prolotherapy for Tendon Injuries"
  description="Prolotherapy is an effective treatment for chronic tendon injuries including tennis elbow, plantar fasciitis and Achilles tendinopathy. Learn about the research and treatment with Dr. Colin MacLeod ND in Halifax."
  focusKeyword="prolotherapy tendon injuries Halifax"
>
  <HeroSection title="Prolotherapy for Tendon Injuries" compact textOnly>
    <nav slot="breadcrumb" class="text-emerald-300 text-sm mb-4">
      <a href="/prolotherapy" class="hover:text-white transition-colors">Prolotherapy</a>
      <span class="mx-2">/</span>
      <span class="text-white">Tendon Injuries</span>
    </nav>
    <p>Chronic tendon injuries (tendinopathies) are notoriously difficult to treat. Prolotherapy offers an evidence-based approach that stimulates tissue repair rather than simply masking symptoms.</p>
    <CTAButton slot="cta" />
  </HeroSection>

  <!-- Understanding Tendinopathy -->
  <section class="py-16 lg:py-24 bg-white">
    <div class="section-shell">
      <div class="max-w-4xl mx-auto">
        <h2 class="text-3xl sm:text-4xl font-serif font-bold text-emerald-950 mb-8">Understanding Chronic Tendon Injuries</h2>
        <div class="prose prose-lg prose-emerald max-w-none">
          <p>
            Chronic tendon injuries, now more accurately called tendinopathies rather than tendinitis, involve degeneration of tendon tissue rather than simple inflammation. Years of research have shown that these conditions involve failed healing attempts, disorganized collagen and changes in the tendon's cellular structure.
          </p>
          <p>
            This is why anti-inflammatory treatments often provide only temporary relief: they address inflammation that may not be the primary problem. Prolotherapy takes a different approach: it stimulates a controlled healing response that can restart the repair process and strengthen the damaged tissue.
          </p>
          <p>
            The strongest research evidence for prolotherapy exists for three common tendinopathies: lateral epicondylosis (tennis elbow), plantar fasciitis and Achilles tendinopathy.
          </p>
        </div>
      </div>
    </div>
  </section>

  <!-- Tennis Elbow Section -->
  <section id="tennis-elbow" class="py-16 lg:py-24 bg-emerald-50">
    <div class="section-shell">
      <div class="grid lg:grid-cols-2 gap-12 items-start">
        <div>
          <div class="inline-block bg-emerald-700 text-white text-sm font-semibold px-4 py-1 rounded-full mb-4">Strong Evidence</div>
          <h2 class="text-3xl sm:text-4xl font-serif font-bold text-emerald-950 mb-6">Tennis Elbow (Lateral Epicondylosis)</h2>
          <div class="prose prose-lg prose-emerald">
            <p>
              Lateral epicondylosis affects the tendons on the outside of the elbow and causes pain with gripping, lifting and twisting motions. Despite its name, it affects many people who don't play tennis, and any repetitive arm activity can cause it.
            </p>
            <p>
              Tennis elbow has the strongest evidence base of any condition treated with prolotherapy. Multiple randomized controlled trials and a 2022 meta-analysis of 8 studies (354 patients) have demonstrated that dextrose prolotherapy is superior to control treatments.
            </p>
          </div>
        </div>
        <div class="bg-white rounded-2xl p-8 shadow-lg">
          <h3 class="text-xl font-serif font-semibold text-emerald-950 mb-6">Research Highlights</h3>
          <div class="space-y-6">
            <div class="border-l-4 border-emerald-700 pl-4">
              <p class="text-slate-600 mb-2">
                <strong>2022 Meta-Analysis:</strong> Pooled data from 8 RCTs showed prolotherapy superior to active controls at 12 weeks for pain intensity (SMD = -0.44) and DASH functional scores (mean difference -15.04 points, exceeding the clinically meaningful threshold).<sup>1</sup>
              </p>
            </div>
            <div class="border-l-4 border-emerald-700 pl-4">
              <p class="text-slate-600 mb-2">
                <strong>Scarpone 2008 RCT:</strong> At 16 weeks, 100% of prolotherapy patients reported pain ≤1 on a 10-point scale compared to 0% of controls. At 52 weeks, 60% of prolotherapy patients had no pain while 80% of controls still had pain affecting daily activities.<sup>2</sup>
              </p>
            </div>
            <div class="border-l-4 border-emerald-700 pl-4">
              <p class="text-slate-600 mb-2">
                <strong>Rabago 2013 RCT:</strong> Both dextrose and dextrose-morrhuate prolotherapy improved PRTEE scores by 41-53% from baseline, with 75-78% of patients reporting satisfaction with treatment.<sup>3</sup>
              </p>
            </div>
          </div>
        </div>
      </div>
    </div>
  </section>

  <!-- Plantar Fasciitis Section -->
  <section id="plantar-fasciitis" class="py-16 lg:py-24 bg-white">
    <div class="section-shell">
      <div class="grid lg:grid-cols-2 gap-12 items-start">
        <div class="lg:order-2">
          <div class="inline-block bg-emerald-700 text-white text-sm font-semibold px-4 py-1 rounded-full mb-4">Strong Evidence</div>
          <h2 class="text-3xl sm:text-4xl font-serif font-bold text-emerald-950 mb-6">Plantar Fasciitis</h2>
          <div class="prose prose-lg prose-emerald">
            <p>
              Plantar fasciitis causes heel pain, particularly with the first steps in the morning. It involves degeneration of the plantar fascia where it attaches to the heel bone. While many cases resolve with conservative treatment, chronic plantar fasciitis can be frustratingly persistent.
            </p>
            <p>
              A 2021 meta-analysis of 8 randomized controlled trials (479 patients) confirmed that prolotherapy effectively reduces pain, improves foot function and even decreases plantar fascia thickness, suggesting actual tissue healing rather than just symptom relief.
            </p>
          </div>
        </div>
        <div class="bg-emerald-50 rounded-2xl p-8 shadow-lg lg:order-1">
          <h3 class="text-xl font-serif font-semibold text-emerald-950 mb-6">Research Highlights</h3>
          <div class="space-y-6">
            <div class="border-l-4 border-emerald-700 pl-4">
              <p class="text-slate-600 mb-2">
                <strong>2021 Meta-Analysis:</strong> Pooled results showed significant pain reduction at 3 months (mean difference -1.76 on VAS), improved Foot Function Index scores and reduced fascia thickness.<sup>4</sup>
              </p>
            </div>
            <div class="border-l-4 border-emerald-700 pl-4">
              <p class="text-slate-600 mb-2">
                <strong>Double-Blind RCT:</strong> 89% of prolotherapy patients achieved meaningful clinical improvement compared to only 33% of controls. Pain scores improved from 7.0 to 3.1 with prolotherapy vs 6.9 to 5.8 with saline.<sup>5</sup>
              </p>
            </div>
            <div class="border-l-4 border-emerald-700 pl-4">
              <p class="text-slate-600 mb-2">
                <strong>Ersen 2018 RCT:</strong> Prolotherapy with 15% dextrose showed significantly greater improvement in pain scores than control, with benefits maintained at 1-year follow-up.<sup>6</sup>
              </p>
            </div>
          </div>
        </div>
      </div>
    </div>
  </section>

  <!-- Achilles Tendinopathy Section -->
  <section id="achilles" class="py-16 lg:py-24 bg-emerald-50">
    <div class="section-shell">
      <div class="grid lg:grid-cols-2 gap-12 items-start">
        <div>
          <div class="inline-block bg-emerald-600 text-white text-sm font-semibold px-4 py-1 rounded-full mb-4">Moderate Evidence</div>
          <h2 class="text-3xl sm:text-4xl font-serif font-bold text-emerald-950 mb-6">Achilles Tendinopathy</h2>
          <div class="prose prose-lg prose-emerald">
            <p>
              Achilles tendinopathy causes pain in the tendon connecting the calf muscles to the heel. It's common in runners and people who increase their activity level too quickly. The standard treatment is eccentric loading exercises (the Alfredson protocol), but this can take months to work.
            </p>
            <p>
              A randomized controlled trial published in the British Journal of Sports Medicine compared prolotherapy, eccentric exercises and combined treatment. The results showed that adding prolotherapy to exercises provides faster symptom relief, though long-term outcomes are similar.
            </p>
          </div>
        </div>
        <div class="bg-white rounded-2xl p-8 shadow-lg">
          <h3 class="text-xl font-serif font-semibold text-emerald-950 mb-6">Research Highlights</h3>
          <div class="space-y-6">
            <div class="border-l-4 border-emerald-700 pl-4">
              <p class="text-slate-600 mb-2">
                <strong>Yelland 2011 RCT:</strong> 43 patients randomized to eccentric exercises alone, prolotherapy alone, or combined treatment. At 12 months, clinically meaningful improvement was achieved by 73% (exercises), 79% (prolotherapy), and 86% (combined).<sup>7</sup>
              </p>
            </div>
            <div class="border-l-4 border-emerald-700 pl-4">
              <p class="text-slate-600 mb-2">
                <strong>Faster Results:</strong> Combined treatment showed significantly better results than exercises alone at both 6 weeks (p=0.005) and 12 months (p=0.007). Pain and stiffness reductions occurred earlier with prolotherapy.
              </p>
            </div>
            <div class="border-l-4 border-emerald-700 pl-4">
              <p class="text-slate-600 mb-2">
                <strong>Full Recovery:</strong> At 12 months, 71% of prolotherapy patients and 64% of combined treatment patients achieved full recovery (VISA-A score ≥90) compared to 53% with exercises alone.
              </p>
            </div>
          </div>
        </div>
      </div>
    </div>
  </section>

  <!-- Treatment Protocol Section -->
  <section class="py-16 lg:py-24 bg-emerald-950">
    <div class="section-shell">
      <h2 class="text-3xl sm:text-4xl font-serif font-bold text-white mb-12 text-center">Treatment Protocol</h2>
      <div class="grid md:grid-cols-3 gap-8">
        <div class="bg-white/10 rounded-2xl p-8">
          <div class="text-4xl font-bold text-white mb-4">3-6</div>
          <h3 class="text-xl font-serif font-semibold text-white mb-3">Sessions</h3>
          <p class="text-emerald-200">
            Most tendon injuries require 3-6 treatment sessions. Response varies by condition and severity; some patients improve after 2-3 treatments while others need the full series.
          </p>
        </div>
        <div class="bg-white/10 rounded-2xl p-8">
          <div class="text-4xl font-bold text-white mb-4">2-4</div>
          <h3 class="text-xl font-serif font-semibold text-white mb-3">Weeks Apart</h3>
          <p class="text-emerald-200">
            Sessions are typically spaced 2-4 weeks apart to allow the healing response to develop between treatments. This timing follows the protocols used in successful clinical trials.
          </p>
        </div>
        <div class="bg-white/10 rounded-2xl p-8">
          <div class="text-4xl font-bold text-white mb-4">12.5-20%</div>
          <h3 class="text-xl font-serif font-semibold text-white mb-3">Dextrose Concentration</h3>
          <p class="text-emerald-200">
            We use dextrose concentrations consistent with those used in clinical trials, typically 12.5-20% depending on the treatment area and patient factors.
          </p>
        </div>
      </div>
    </div>
  </section>

  <!-- Expected Outcomes Section -->
  <section class="py-16 lg:py-24 bg-white">
    <div class="section-shell">
      <div class="max-w-4xl mx-auto">
        <h2 class="text-3xl sm:text-4xl font-serif font-bold text-emerald-950 mb-8 text-center">What to Expect</h2>
        <div class="grid md:grid-cols-2 gap-8">
          <div class="bg-emerald-50 rounded-2xl p-8">
            <h3 class="text-xl font-serif font-semibold text-emerald-950 mb-4">Timeline</h3>
            <ul class="space-y-4 text-slate-600">
              <li class="flex gap-3">
                <svg class="w-6 h-6 text-emerald-600 flex-shrink-0" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                  <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 8v4l3 3m6-3a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                </svg>
                <span><strong>Days 1-3:</strong> Mild soreness at injection sites (normal part of the healing response)</span>
              </li>
              <li class="flex gap-3">
                <svg class="w-6 h-6 text-emerald-600 flex-shrink-0" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                  <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 8v4l3 3m6-3a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                </svg>
                <span><strong>Weeks 2-4:</strong> Gradual improvement begins as tissue repair progresses</span>
              </li>
              <li class="flex gap-3">
                <svg class="w-6 h-6 text-emerald-600 flex-shrink-0" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                  <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 8v4l3 3m6-3a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                </svg>
                <span><strong>Weeks 8-16:</strong> Significant improvement typically evident by 3rd-4th treatment</span>
              </li>
              <li class="flex gap-3">
                <svg class="w-6 h-6 text-emerald-600 flex-shrink-0" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                  <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 8v4l3 3m6-3a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                </svg>
                <span><strong>6-12 months:</strong> Continued improvement; studies show benefits persist long-term</span>
              </li>
            </ul>
          </div>
          <div class="bg-emerald-50 rounded-2xl p-8">
            <h3 class="text-xl font-serif font-semibold text-emerald-950 mb-4">Success Rates from Research</h3>
            <ul class="space-y-4 text-slate-600">
              <li class="flex gap-3">
                <svg class="w-6 h-6 text-emerald-600 flex-shrink-0" fill="currentColor" viewBox="0 0 20 20">
                  <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z" clip-rule="evenodd"></path>
                </svg>
                <span><strong>Tennis elbow:</strong> 100% of patients achieved pain ≤1 at 16 weeks in one RCT</span>
              </li>
              <li class="flex gap-3">
                <svg class="w-6 h-6 text-emerald-600 flex-shrink-0" fill="currentColor" viewBox="0 0 20 20">
                  <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z" clip-rule="evenodd"></path>
                </svg>
                <span><strong>Plantar fasciitis:</strong> 89% achieved meaningful improvement vs 33% controls</span>
              </li>
              <li class="flex gap-3">
                <svg class="w-6 h-6 text-emerald-600 flex-shrink-0" fill="currentColor" viewBox="0 0 20 20">
                  <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z" clip-rule="evenodd"></path>
                </svg>
                <span><strong>Achilles:</strong> 79% achieved clinically meaningful improvement at 12 months</span>
              </li>
              <li class="flex gap-3">
                <svg class="w-6 h-6 text-emerald-600 flex-shrink-0" fill="currentColor" viewBox="0 0 20 20">
                  <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm3.707-9.293a1 1 0 00-1.414-1.414L9 10.586 7.707 9.293a1 1 0 00-1.414 1.414l2 2a1 1 0 001.414 0l4-4z" clip-rule="evenodd"></path>
                </svg>
                <span><strong>Combined prolo + exercises:</strong> 86% achieved meaningful improvement for Achilles</span>
              </li>
            </ul>
          </div>
        </div>
      </div>
    </div>
  </section>

  <!-- FAQ Section -->
  <section class="py-16 lg:py-24 bg-white">
    <div class="section-shell">
      <h2 class="text-3xl sm:text-4xl font-serif font-bold text-emerald-950 mb-12 text-center">Frequently Asked Questions</h2>
      <FAQAccordion items={[
        { question: "Will I need to stop exercising during treatment?", answer: "<p>No but avoid intense exercise on day of treatment. Return to regular intensity when comfort level allows (day 2 or later).</p>" },
        { question: "How does prolotherapy compare to cortisone for tendon injuries?", answer: "<p>Cortisone can provide quick pain relief but doesn't address the underlying tendon degeneration. Research has shown that repeated cortisone injections can actually weaken tendon tissue and increase the risk of rupture. Prolotherapy takes longer to work but aims to strengthen the damaged tissue. For chronic tendinopathies where the goal is lasting repair, prolotherapy is often the better choice.</p>" },
        { question: "What if I've already had cortisone injections?", answer: "<p>It is ok to have prolotherapy 1 week after cortisone injection.</p>" },
        { question: "Is prolotherapy effective for partial tendon tears?", answer: "<p>Yes. Complete tears can be helped with prolotherapy but take much longer for the body to complete its repair process.</p>" },
        { question: "Can prolotherapy help if I've had the problem for years?", answer: "<p>Yes, prolotherapy is often used specifically for chronic, long-standing tendinopathies that haven't responded to other treatments. The studies included patients with symptoms lasting 6 months to several years. Chronic conditions may require more treatment sessions, but there's no point at which prolotherapy becomes ineffective simply because the problem is old.</p>" },
      ]} />
    </div>
  </section>

  <!-- Related Conditions -->
  <section class="py-16 lg:py-24 bg-emerald-50">
    <div class="section-shell">
      <h2 class="text-3xl sm:text-4xl font-serif font-bold text-emerald-950 mb-6 text-center">Related Information</h2>
      <div class="grid md:grid-cols-3 gap-6 max-w-4xl mx-auto">
        <a href="/tennis-elbow" class="group bg-white rounded-2xl p-6 shadow-lg hover:shadow-xl transition-shadow">
          <h3 class="text-lg font-serif font-semibold text-emerald-950 mb-2 group-hover:text-emerald-700 transition-colors">Tennis Elbow</h3>
          <p class="text-slate-600 text-sm">Learn more about lateral epicondylosis and all treatment options.</p>
        </a>
        <a href="/plantar-fasciitis" class="group bg-white rounded-2xl p-6 shadow-lg hover:shadow-xl transition-shadow">
          <h3 class="text-lg font-serif font-semibold text-emerald-950 mb-2 group-hover:text-emerald-700 transition-colors">Plantar Fasciitis</h3>
          <p class="text-slate-600 text-sm">Comprehensive information about heel pain and treatment approaches.</p>
        </a>
        <a href="/achilles-tendinitis" class="group bg-white rounded-2xl p-6 shadow-lg hover:shadow-xl transition-shadow">
          <h3 class="text-lg font-serif font-semibold text-emerald-950 mb-2 group-hover:text-emerald-700 transition-colors">Achilles Tendinopathy</h3>
          <p class="text-slate-600 text-sm">Understanding Achilles tendon problems and treatment options.</p>
        </a>
      </div>
    </div>
  </section>

  <!-- CTA Section -->
  <section class="py-16 lg:py-24 bg-emerald-950">
    <div class="section-shell text-center">
      <h2 class="text-3xl sm:text-4xl font-serif font-bold text-white mb-6">Tired of Chronic Tendon Pain?</h2>
      <p class="text-lg text-emerald-200 max-w-2xl mx-auto mb-8">
        If you've been dealing with tennis elbow, plantar fasciitis, or Achilles tendinopathy that won't resolve, prolotherapy may be the answer. Schedule a consultation to discuss your options.
      </p>
      <CTAButton source="prolotherapy-for-tendon-injuries-cta" />
    </div>
  </section>

  <!-- References Section -->
  <section class="py-12 bg-slate-100">
    <div class="section-shell">
      <h2 class="text-xl font-serif font-bold text-emerald-950 mb-6">References</h2>
      <div class="prose prose-sm prose-slate max-w-none">
        <ol class="text-sm text-slate-600 space-y-2">
          <li>Zhu M, Rabago D, Chung VC, et al. Effects of Hypertonic Dextrose Injection (Prolotherapy) in Lateral Elbow Tendinosis: A Systematic Review and Meta-analysis. Arch Phys Med Rehabil. 2022;103(11):2209-2218.</li>
          <li>Scarpone M, Rabago DP, Zgierska A, Arbogast G, Snell E. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin J Sport Med. 2008;18(3):248-254.</li>
          <li>Rabago D, Lee KS, Ryan M, et al. Hypertonic dextrose and morrhuate sodium injections (prolotherapy) for lateral epicondylosis (tennis elbow): a randomized controlled trial. Am J Phys Med Rehabil. 2013;92(7):587-596.</li>
          <li>Lai CC, et al. Efficacy of prolotherapy for plantar fasciitis: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2021;100(51):e28216.</li>
          <li>Kim E, Lee JH. Autologous platelet-rich plasma versus dextrose prolotherapy for the treatment of chronic recalcitrant plantar fasciitis. PM R. 2014;6(2):152-158.</li>
          <li>Ersen O, Koca K, Akpancar S, et al. A randomized-controlled trial of prolotherapy injections in the treatment of plantar fasciitis. Turk J Phys Med Rehabil. 2018;64(1):59-65.</li>
          <li>Yelland MJ, Sweeting KR, Lyftogt JA, Ng SK, Scuffham PA, Evans KA. Prolotherapy injections and eccentric loading exercises for painful Achilles tendinosis: a randomised trial. Br J Sports Med. 2011;45(5):421-428.</li>
        </ol>
      </div>
    </div>
  </section>
</BaseLayout>
